Weiwei Shao

864 total citations
38 papers, 675 citations indexed

About

Weiwei Shao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiwei Shao has authored 38 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiwei Shao's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Natural product bioactivities and synthesis (3 papers). Weiwei Shao is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Natural product bioactivities and synthesis (3 papers). Weiwei Shao collaborates with scholars based in China, United States and Hong Kong. Weiwei Shao's co-authors include Yasu Jiang, Ying Liu, Dong Xu, Xianchen Liu, Xi Wang, Xiaoyan Shen, Chun Zhou, Pengcheng Yan, Jianyong Dong and Ying Wang and has published in prestigious journals such as Neuroscience, Annals of the Rheumatic Diseases and Phytochemistry.

In The Last Decade

Weiwei Shao

36 papers receiving 673 citations

Peers

Weiwei Shao
Comparison fields: 5 of 83
  • Molecular Biology 424
  • Cancer Research 165
  • Oncology 112
  • Pulmonary and Respiratory Medicine 79
  • Pharmacology 58
Replace Mianhua Wu with:
Mianhua Wu China
Fangtian Fan China
Naoshad Muhammad United States
Jiao Li China
Weili Min China
Zhujun Tan China
Itishree Kaushik United States
Chuan‐Chou Tu Taiwan
Hongfei Tong China
Mianhua Wu China View profile →
Citations per field, relative to Weiwei Shao
Weiwei Shao · 1×
Citations per year, relative to Weiwei Shao
Weiwei Shao · 1×

Countries citing papers authored by Weiwei Shao

Since Specialization
Citations

This map shows the geographic impact of Weiwei Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Shao more than expected).

Fields of papers citing papers by Weiwei Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Shao. The network helps show where Weiwei Shao may publish in the future.

Co-authorship network of co-authors of Weiwei Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Shao. A scholar is included among the top collaborators of Weiwei Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Shao. Weiwei Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 33
5 5
6 11
7 12
8 8
9 4
10 137
11 13
12 26
13 33
14 3
15 43
16 23
17 8
18 57
19 17
20 43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026